-
-
-
-
-
-
-
Nektar Therapeutics Announces Closing of $115 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR)
-
-
-
-
-
-
-
Pre-Open Movers 06/04: (VSAR) (VYGR) (GHDX) Higher; (NKTR) (JNCE) (CFX) Lower (more...)
-
-
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

